About Affinia Therapeutics

Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia Rationally-designed Therapies (ART) platform is created to address key limitations of conventional gene therapies, by developing novel capsids, novel promoters, and novel manufacturing approaches to developing gene therapies for rare and prevalent devastating diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world.

As an early employee you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun.

Our brand new Site Includes: State of the Art lab space & Equipment-
Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More!

Join Us!

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
43 Foundry, Ste 120, Waltham, Massachusetts 02453, US
description icon
Founded
2019
description icon
Keywords
Biotechnology, Research, Discovery, Teamwork, Integrity, Aav, Rare Diseases, Passion, Vector, Passion, Gene Therapy, Teamwork, Aav, Research, Discovery, Biotechnology, Rare Diseases, Integrity, Vector, Capsid, Gene Therapy

Affinia Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Affinia Therapeutics

Who are the decision makers in Affinia Therapeutics?

The decision makers in Affinia Therapeutics are Aaron Tward, Deepak Grover, Evelyn Karim, etc. Click to Find Affinia Therapeutics decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more